OLMALINC and breast cancer: High expression of LINC00263 was a disadvantage in the survival prognosis of lung adenocarcinoma, renal and clear cell carcinomas, colorectal cancer and hepatic carcinoma, but it was a favorable factor in ovarian cancer and had no significant effect in prostate cancer and breast cancer.